Medicine
Lidocaine 5% ointment
Lidocaine 5% ointment is a generic prescription medicine for topical use, made by 26 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Lidocaine
- Brand
- Sold under the generic name
- Strength
- 5%
- Dosage form
- Ointment
- Route
- Topical
- Packs
- 1 tube, 50 g, 1 jar and 103 more
- Manufacturers
- Alembic PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaAurobindo PharmaIndiaSun Pharmaceutical IndustriesIndiaGlenmark PharmaceuticalsIndiaDirect_RxAmneal PharmaceuticalsQuagen PharmaceuticalsEncube EthicalsFougera Pharmaceuticals26 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01BB01 Lidocaine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 June 1972
- Identifiers
- RxCUI 1543069DailyMed set ID 6fe7721d-42b3-4284-936b-a448ca530c45, 4134f30d-5cb0-e14b-e063-6394a90a4523, 9bf01533-ed83-4440-bdc4-4b45729bfc31 +37NDC 72162-2084, 80425-0554, 70518-3746 +37Application ANDA206297, ANDA206498, ANDA211697 +9
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 26 labelers. The register lists 106 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 30 g in 1 tube | 46708-424-30 | Alembic PharmaceuticalsIndia | 11 February 2025 |
| 1 tube in 1 carton / 35.44 g in 1 tube | 46708-424-35 | Alembic PharmaceuticalsIndia | 11 February 2025 |
| 50 g in 1 jar | 46708-424-50 | Alembic PharmaceuticalsIndia | 11 February 2025 |
| 1 tube in 1 carton / 30 g in 1 tube | 62332-424-30 | Alembic PharmaceuticalsIndia | 30 November 2018 |
| 1 tube in 1 carton / 35.44 g in 1 tube | 62332-424-35 | Alembic PharmaceuticalsIndia | 30 November 2018 |
| 50 g in 1 jar | 62332-424-50 | Alembic PharmaceuticalsIndia | 30 November 2018 |
| 1 jar in 1 carton / 50 g in 1 jar | 51672-3008-5 | Sun Pharmaceutical IndustriesIndia | 17 August 1981 |
| 1 tube in 1 carton / 30 g in 1 tube | 51672-3020-2 | Sun Pharmaceutical IndustriesIndia | 25 March 2013 |
| 1 tube in 1 carton / 35.44 g in 1 tube | 51672-3020-9 | Sun Pharmaceutical IndustriesIndia | 25 March 2013 |
| 1 tube in 1 carton / 30 g in 1 tube | 59651-591-30 | Aurobindo PharmaIndia | 18 June 2024 |
| 1 tube in 1 carton / 35.44 g in 1 tube | 59651-591-35 | Aurobindo PharmaIndia | 18 June 2024 |
| 50 g in 1 jar | 59651-591-50 | Aurobindo PharmaIndia | 18 June 2024 |
| 1 tube in 1 carton / 35.44 g in 1 tube | 68462-418-20 | Glenmark PharmaceuticalsIndia | 1 July 2016 |
| 50 g in 1 jar | 68462-418-27 | Glenmark PharmaceuticalsIndia | 1 July 2016 |
| 1 tube in 1 carton / 30 g in 1 tube | 33342-405-30 | Macleods PharmaceuticalsIndia | 1 March 2021 |
| 1 tube in 1 carton / 35.44 g in 1 tube | 33342-405-35 | Macleods PharmaceuticalsIndia | 1 March 2021 |
| 50 g in 1 jar | 33342-405-44 | Macleods PharmaceuticalsIndia | 18 November 2025 |
| 1 tube in 1 carton / 50 g in 1 tube | 33342-405-50 | Macleods PharmaceuticalsIndia | 1 March 2021 |
| 1 tube in 1 carton / 30 g in 1 tube | 65162-918-30 | Amneal Pharmaceuticals | 10 August 2015 |
| 1 tube in 1 carton / 35.44 g in 1 tube | 65162-918-38 | Amneal Pharmaceuticals | 10 August 2015 |
| 150 g in 1 jar | 65162-918-41 | Amneal Pharmaceuticals | 10 August 2015 |
| 250 g in 1 jar | 65162-918-45 | Amneal Pharmaceuticals | 10 August 2015 |
| 50 g in 1 jar | 65162-918-53 | Amneal Pharmaceuticals | 10 August 2015 |
| 1 tube in 1 carton / 35.44 g in 1 tube | 21922-107-13 | Encube Ethicals | 20 June 2026 |
| 50 g in 1 jar | 21922-107-61 | Encube Ethicals | 20 June 2026 |
| 1 tube in 1 carton / 35.44 g in 1 tube | 0168-0204-37 | Fougera Pharmaceuticals | 30 June 1972 |
| 1 tube in 1 carton / 35.44 g in 1 tube | 70752-113-03 | Quagen Pharmaceuticals | 20 April 2021 |
| 50 g in 1 jar | 70752-113-04 | Quagen Pharmaceuticals | 20 April 2021 |
| 150 g in 1 jar | 70752-113-07 | Quagen Pharmaceuticals | 20 April 2021 |
| 250 g in 1 jar | 70752-113-13 | Quagen Pharmaceuticals | 20 April 2021 |
| 50 g in 1 jar | 0362-0221-10 | Septodont | 20 May 2015 |
| 35.44 g in 1 bottle | 72189-165-35 | Direct RX | 8 January 2021 |
| 35.44 g in 1 tube | 72189-168-35 | Direct RX | 12 January 2021 |
| 50 g in 1 tube | 72189-168-50 | Direct RX | 12 January 2021 |
| 50 g in 1 jar | 72189-211-50 | Direct RX | 7 May 2021 |
| 50 g in 1 carton | 72189-488-50 | Direct_Rx | 7 June 2023 |
| 35.44 g in 1 tube | 72189-493-35 | Direct_Rx | 22 June 2023 |
| 50 g in 1 jar | 72189-499-50 | Direct_Rx | 14 July 2023 |
| 35 g in 1 carton | 72189-601-35 | Direct_rx | 23 December 2024 |
| 50 g in 1 jar | 72189-692-50 | Direct_Rx | 28 September 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 November 1948 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Lidocaine
Clinical summary
Lidocaine is an amide local anesthetic. It is available as injection, ointment and patches for infiltration, perineural and topical use. MedsAcross supplies Lidocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LidocaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Xylocaine prescribing information (Fresenius Kabi) · U.S. National Library of Medicine, DailyMed
Need Lidocaine 5% ointment for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.